viernes, 28 de abril de 2017

Ivanhoe's Top 5 Reports This Week


Hagerstown, Md. (Ivanhoe Newswire) — The number of tummy tucks has risen by more than 100 percent over the last ten years. But this surgery, which targets stubborn belly fat, is expensive and can be risky.  Here are details on how traditional surgery stacks up against a topical treatment that literally freezes the fat away.

AMAZE for AFib (2nd Week)

ATLANTA. (Ivanhoe Newswire) — More than five million Americans have atrial fibrillation, or AFib.  It’s a condition that causes an irregular heartbeat, greatly increasing the risk of stroke. Researchers are testing a new procedure to see if it is effective in blocking off the small section of tissue responsible for the arrhythmia.

ORLANDO, Fla. (Ivanhoe Newswire) — About 230,000 people injure their Achilles tendon each year in the U.S., and that number is on the rise. Anyone can suffer from this injury, but there are some factors that put you at more risk.

SAN DIEGO, Calif. (Ivanhoe Newswire) — The American Academy of Ophthalmology said cataracts affect nearly 25 million people over 40. Three to four million of them have surgery to fix the clouded, dim vision cataracts cause every year. Now, a cutting-edge lens is now making all the difference for some patients.

BALTIMORE, Md. (Ivanhoe Newswire) — Researchers say they now have evidence that too much of a good thing can possibly damage your heart. The results of a new study suggest that calcium supplements may raise the risk of plaque buildup in arteries.

Give the gift of health news!
Click here to sign up your friends and loved ones for the 

First to Know Newsletter!
Smart Living for this week:

Cash Isn’t King Anymore

The Myth Of Busyness

What Music Do Dogs Prefer?

Uses For Vaseline … Really!

Doctor's In-depth Interview of the week
Breast Cancer Vaccine Personalized - In-Depth Doctor Interview


Quote of the week:

The greatest test of courage on the earth is to bear defeat without losing heart.” 

— Robert Ingersoll

Website Information:

Content Licensing:

No hay comentarios:

Publicar un comentario